Celltrion reports interim phase I data of COVID-19 treatment candidate CT-P59 in healthy subjects Sep. 15, 2020
InflaRx initiates phase III of phase II/III study with IFX-1 in severe COVID-19-induced pneumonia Sep. 15, 2020
RSS